Plasmin-a2-plasmin inhibitor complex in plasma of patients with thromboembolic diseases. 1989

K Wada, and H Takahashi, and W Tatewaki, and S Takizawa, and A Shibata
First Department of Internal Medicine, Niigata University School of Medicine, Japan.

Plasmin generation in vivo was assessed by measuring plasma levels of plasmin-a2-plasmin inhibitor complex (PAP) with an ELISA in 42 patients with arterial or venous thromboembolic diseases. Plasma concentration of PAP was markedly elevated in patients with venous thromboembolic diseases during acute illness (3.32 +/- 3.71 ug/ml, mean +/- SD) as compared to healthy subjects (0.24 +/- 0.13 ug/ml, n = 14), while it was nearly normal (0.30 +/- 0.13 ug/ml) in patients with venous thromboembolic diseases in chronic stage. Patients with arterial thromboembolism had modestly elevated PAP; 1.05 +/- 0.77 ug/ml during acute episode, and 0.84 +/- 0.40 ug/ml in chronic stage. These results indicate that excessive activation of fibrinolytic system (plasmin generation in vivo) occurs actually in many patients with thrombotic diseases, especially in venous thromboembolic diseases during acute illness.

UI MeSH Term Description Entries
D008297 Male Males
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D005337 Fibrin A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot. Antithrombin I
D005341 Fibrinolysin A product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins. Plasmin,Fibrogammin,Glu-Plasmin,Protease F,Thrombolysin,Glu Plasmin
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000073718 Pancreatitis-Associated Proteins C-type lectins that restrict growth of bacteria in the intestinal epithelia and have bactericidal activity against gram-positive and gram-negative bacteria. They also regulate proliferation and differentiation of KERATINOCYTES following injury. Human pancreatitis-associated protein-1 (Reg3a) is overexpressed by pancreatic ACINAR CELLS in patients with CHRONIC PANCREATITIS. It is also highly expressed by pancreatic, bladder, and gastrointestinal cancer cells and may serve as a diagnostic biomarker. Regenerating Islet-Derived Protein,Pancreatitis-Associated Protein,Pancreatitis-Associated Protein-1,Regenerating Islet-Derived Protein 3,Regenerating Islet-Derived Proteins,Islet-Derived Protein, Regenerating,Pancreatitis Associated Protein,Pancreatitis Associated Protein 1,Pancreatitis Associated Proteins,Protein, Pancreatitis-Associated,Protein, Regenerating Islet-Derived,Regenerating Islet Derived Protein,Regenerating Islet Derived Protein 3,Regenerating Islet Derived Proteins
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute

Related Publications

K Wada, and H Takahashi, and W Tatewaki, and S Takizawa, and A Shibata
July 1988, American journal of hematology,
K Wada, and H Takahashi, and W Tatewaki, and S Takizawa, and A Shibata
November 1989, Arthritis and rheumatism,
K Wada, and H Takahashi, and W Tatewaki, and S Takizawa, and A Shibata
February 2003, Rheumatology (Oxford, England),
K Wada, and H Takahashi, and W Tatewaki, and S Takizawa, and A Shibata
January 1958, Archivos. Hospital Universitario General Calixto Garcia,
K Wada, and H Takahashi, and W Tatewaki, and S Takizawa, and A Shibata
July 1983, Bulletin of the Osaka Medical School,
K Wada, and H Takahashi, and W Tatewaki, and S Takizawa, and A Shibata
July 1993, Rinsho byori. The Japanese journal of clinical pathology,
K Wada, and H Takahashi, and W Tatewaki, and S Takizawa, and A Shibata
January 1996, Clinica chimica acta; international journal of clinical chemistry,
K Wada, and H Takahashi, and W Tatewaki, and S Takizawa, and A Shibata
December 2004, Nihon rinsho. Japanese journal of clinical medicine,
K Wada, and H Takahashi, and W Tatewaki, and S Takizawa, and A Shibata
September 1999, Nihon rinsho. Japanese journal of clinical medicine,
K Wada, and H Takahashi, and W Tatewaki, and S Takizawa, and A Shibata
September 1990, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
Copied contents to your clipboard!